Prof. Seong Soo Joo | Natural chemistry | Best Researcher Award

Prof. Seong Soo Joo | Natural chemistry | Best Researcher Award

Prof. Seong Soo Joo, Gangneung-Wonju National University, South Korea

Dr. Joo Seong Soo (PhD) is a distinguished Professor at Gangneung-Wonju National University (GWNU) and CEO of HUSCION, specializing in medical microbiology, natural chemistry, and immunopharmacology πŸ§¬πŸ”¬. With a career spanning academia and the pharmaceutical industry, he has led pioneering research in drug discovery, focusing on Alzheimer’s disease and other challenging illnesses πŸ’ŠπŸ§ . Dr. Joo has developed over 1,000 lead compounds and holds 100+ patents πŸ“œ. His expertise in molecular cell biology, immunology, and pharmacology has earned him prestigious awards, including the Ministry of Health and Welfare Research Excellence Award πŸ†.

Professoinal Profile:

Scopus

Suitability for Best Researcher Award

Dr. Joo Seong Soo is a highly suitable candidate for the Best Researcher Award due to his exceptional contributions to drug discovery, medical microbiology, and immunopharmacology. His work in Alzheimer’s research, immunotherapy, and pharmaceutical innovations has had a profound impact on both academia and the pharmaceutical industry. His ability to bridge research and commercial drug development strengthens his candidacy

Education & Experience πŸŽ“πŸ’Ό

πŸ“ Education:

  • Ph.D. in Immunology & Pharmacology – Chung-Ang University, Korea (2003) πŸŽ“

  • M.Sc. in Medical Microbiology – Long Island University, USA (1992) πŸ₯

πŸ“ Academic Experience:

  • Professor, GWNU (2010–Present) πŸ“š

  • Research Professor, Chungbuk National University (2007–2010) πŸ”¬

  • Research Professor, Chung-Ang University (2004–2007) πŸ›οΈ

πŸ“ Industry Experience:

  • CEO, HUSCION (2018–Present) 🏒

  • New Drug Development Manager, HanDok Pharma (2000–2002) πŸ’Š

  • Clinical Trial Manager, GSK Korea (1998–2000) 🌍

  • New Drug Clinical Team Manager, JW Pharma (1993–1998) πŸ₯

Professional Development πŸš€

Dr. Joo Seong Soo has played a transformative role in pharmaceutical R&D, blending academic expertise with industry leadership πŸ”¬πŸ’‘. As the founder and CEO of HUSCION, he has driven cutting-edge drug discovery, with a focus on molecular biology, immunology, and pharmacology 🧬. His work has led to the development of innovative therapeutics, particularly in treating neurodegenerative diseases like Alzheimer’s 🧠. In addition to research, he has been a dedicated educator, mentoring students and fostering collaborative projects between academia and industry πŸ“šπŸ€. His global experience in clinical trials and drug development has positioned him as a leading expert in life sciences 🌍.

Research Focus πŸ”¬πŸ§ͺ

Dr. Joo’s research encompasses medical microbiology, natural chemistry, and immunopharmacology, with an emphasis on drug discovery and molecular therapeutics πŸ’Š. His expertise in molecular cell biology, gene mutation analysis, and therapeutic cell manipulation has led to groundbreaking advancements in pharmaceuticals 🧬. A core focus of his work is on developing novel treatments for Alzheimer’s disease, utilizing bioactive compounds and immunomodulatory approaches 🧠. Additionally, he explores antimicrobial resistance, inflammatory diseases, and targeted drug delivery systems 🦠. His extensive publication record and 100+ patents underscore his impact on global health and medicine 🌎πŸ₯.

Awards & Honors πŸ†πŸŽ–

  • Marquis Who’s Who in the World 🌍

  • Marquis Who’s Who in Medicine and Healthcare πŸ₯

  • Outstanding Researcher Award, Gangneung-Wonju National University πŸ“œ

  • Ministry of Health and Welfare Research Excellence Award πŸ…

  • Star Laboratory Award, GWNU ⭐

  • Associate Editor, Journal of Biomedical Research πŸ“–

  • Meber, Society of Molecular and Cellular Biology, Institute of Food Technologists πŸ§ͺ

Publication Top Notes:

πŸ“„ “Serotonin Influences Insulin Secretion in Rat Insulinoma INS – πŸ“‘ Cited by: 1
πŸ“„ “Improvement of Cognitive Function by Fermented Panax ginseng C.A. Meyer Berries Extracts in an AF64A-Induced Memory Deficit Model” – πŸ“‘ Cited by: 3
πŸ“„ “Effectiveness of Combinational Treatments for Alzheimer’s Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes”– πŸ“‘ Cited by: 4
πŸ“„ “Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress” – πŸ“‘ Cited by: 20

 

 

 

Prof. Thomas Mavromoustakos| Organic chemistry | Excellence in Research

Prof. Thomas Mavromoustakos| Organic chemistry | Excellence in Research

Prof. thomas mavromoustakos| Organic chemistry | Excellence in Research

Professor Thomas Mavromoustakos is a distinguished figure in organic chemistry, currently serving as a professor at the National and Kapodistrian University of Athens (NKUA). His academic journey began with a B.Sc. in Chemistry from NKUA in 1985, followed by an M.Sc. and Ph.D. in Medicinal Chemistry from the University of Connecticut in 1987 and 1990, respectively. His research interests encompass the use of spectroscopic techniques to study drug-membrane interactions and the rational design of new drugs. With over 300 publications and more than 6,000 citations, his contributions to the field are widely recognized.

Professional Profile:

Google Scholar

Suitability for Excellence in Research Award

Professor Thomas Mavromoustakos stands as a highly suitable candidate for the Excellence in Research Award due to his extensive and influential contributions to the field of organic and medicinal chemistry. His academic and professional journey reflects a deep commitment to scientific discovery and innovation, supported by a remarkable publication record, impactful research, and notable professional recognition.

Education and Experience

  • πŸŽ“ 1985: B.Sc. in Chemistry, University of Athens, Greece
  • πŸŽ“ 1987: M.Sc. in Medicinal Chemistry, University of Connecticut, U.S.A.
  • πŸŽ“ 1990: Ph.D. in Medicinal Chemistry, University of Connecticut, U.S.A.
  • πŸ§‘β€πŸ”¬ 1991: Researcher at the National Hellenic Research Foundation (NHRF)
  • πŸ‘¨β€πŸ« 2007 – 2012: Associate Professor, Chemistry Department, NKUA
  • πŸ‘¨β€πŸ« 2012 – Present: Professor, Chemistry Department, NKUA
  • πŸ§‘β€πŸ”¬ 2022: Director of Organic Chemistry Laboratory and Vice-President of Chemistry Department, NKUA

Professional Development

Throughout his illustrious career, Professor Mavromoustakos has demonstrated a steadfast commitment to advancing the field of organic chemistry. His teaching portfolio includes undergraduate courses such as Organic Chemistry Laboratory for Biologists and Chemists, as well as NMR Spectroscopy and Molecular Modeling. At the postgraduate level, he imparts knowledge on NMR Spectroscopy, Molecular Modeling, the Element of Carbon, and Rational Drug Design. His research endeavors are centered on employing spectroscopic techniques to delve into drug-membrane interactions, utilizing molecular docking and dynamics to elucidate drug actions, and applying quantitative structure-activity relationships for the rational design of novel drugs. His prolific contributions to scientific literature, with over 300 publications and an H-index of 38, underscore his influence and dedication to the scientific community.

Research Focus

Professor Mavromoustakos’s research is deeply rooted in the exploration of drug interactions at the molecular level. He specializes in using spectroscopic techniques to study how drugs interact with membrane bilayers, providing insights into their orientation and dynamics. His work also involves molecular docking and dynamics studies to understand drug actions within their active sites, contributing to the rational design of new therapeutic agents. By integrating quantitative structure-activity relationships, he aims to predict and enhance the efficacy of drug candidates. His interdisciplinary approach bridges chemistry, biology, and pharmacology, leading to significant advancements in medicinal chemistry.

Awards and Honors

  • πŸ† 1998, 2022: Prizes by the Academy of Athens for research work on hypertension
  • πŸŽ“ Fulbright Scholarship: Recognized for academic excellence
  • πŸŽ“ Royal Society Scholarship: Honored for contributions to science
  • πŸ… Theology Ph.D. Recognition: Honored by the Thermal Society and the Polytechnic Association for achieving a Ph.D. in Theology
  • πŸ“ Top 25 Hottest Articles: Article in Bioorganic & Medicinal Chemistry Letters selected among the top 25 hottest articles Sources

Publication Top Notes:

  • Functional components of carob fruit: Linking the chemical and biological space
    • Cited by: 213
  • An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic…
    • Cited by: 161
  • Comparison of classical and ultrasound-assisted isolation procedures of cellulose from kenaf (Hibiscus cannabinus L.) and eucalyptus (Eucalyptus rodustrus Sm.)
    • Cited by: 138
  • Synthesis, pH-dependent structural characterization, and solution behavior of aqueous aluminum and gallium citrate complexes
    • Cited by: 136
  • Strategies in the rational drug design
    • Cited by: 13

Dr. Tat’yana Khonina | Organic Synthesis | Best Researcher Award

Dr. Tat’yana Khonina | Organic Synthesis | Best Researcher Award

Dr. Tat’yana Khonina, Insititute of Organic Synthesis of the Ural Branch of the Russian Academy of Sciences , Russia

Dr. Tatiana Grigorievna Khonina, a prominent representative of the Ural school of organic chemists, carries forward the legacy of academician I.Ya. Postovsky. A graduate of the Ural State University named after A.M. Gorky, she works at the I.Ya. Postovsky Institute of Organic Synthesis (IOS UB RAS). As a Doctor of Chemical Sciences, leading researcher, and group leader, her focus is on functional organic compounds involving silicon, titanium, and other elements, with innovative applications in medicine and veterinary science. She holds over 40 patents and enriches the academic community through her teaching at Ural SAU. πŸŒŸπŸ”¬πŸ“š

Professional Profile:

Scopus

Orcid

Suitability for Best Researcher Award

Dr. Tatiana Grigorievna Khonina’s contributions to organic chemistry, combined with her leadership, innovation, and commitment to education, make her a stellar candidate for the Best Researcher Award. Her work not only advances fundamental science but also delivers meaningful applications in medicine and veterinary fields, showcasing her profound impact on both science and society

Education and Experience

  • πŸŽ“ Graduated from the Chemical Faculty, Ural State University named after A.M. Gorky
  • πŸ›οΈ Researcher at I.Ya. Postovsky Institute of Organic Synthesis (IOS UB RAS)
  • πŸ‘©β€πŸ”¬ Doctor of Chemical Sciences
  • πŸŽ“ Lecturer at Ural State Agrarian University (FSBEI HE Ural SAU)
  • πŸ… Leader of a research group specializing in organic synthesis

Professional Development

Dr. Khonina has devoted her career to advancing organic synthesis, particularly involving functional compounds of silicon, titanium, and other elements. She bridges fundamental research with applied sciences, focusing on medical and veterinary applications. Her work, supported by over 40 patents, showcases her innovative approach to creating biologically active substances and their preparation methods. Balancing research and academia, she mentors students and contributes to the Ural scientific community. Her leadership has made a significant impact on both scientific advancements and educational excellence. πŸŒπŸ”¬πŸ†

Research Focus

Dr. Khonina’s research encompasses cutting-edge areas in organic chemistry:

  • πŸ§ͺ Formation Reactions: Understanding mechanisms of functional organic compounds.
  • 🌟 Chemical Transformations: Exploring reactivity in silicon- and titanium-based systems.
  • πŸ’Š Biomedical Applications: Developing compounds for medical and veterinary use.
  • πŸ“œ Patented Innovations: Over 40 patents in biologically active substances and methods.
    Her interdisciplinary work addresses global challenges, making strides in health sciences and sustainable chemistry. πŸŒ±πŸ§¬πŸ”§

Awards and Honors

  • πŸ† More than 40 patents for biologically active substances and methods
  • πŸ… Leader of a renowned research group at IOS UB RAS
  • 🌟 Recognized contributor to the Ural school of organic chemists
  • πŸ“œ Esteemed lecturer and mentor at Ural State Agrarian University
  • πŸ₯‡ Developer of innovative applications in medical and veterinary chemistry

Publication Top Notes:

  • πŸ“œ Iron(III) Monoglycerolate as a New Biocompatible Precursor in the Synthesis of Bioactive Nanocomposite Glycerohydrogels – Cited by 1
  • 🧲 Nanocomposite Material Based on Fe3O4 Magnetic Nanoparticles Modified with Iron and Silicon Glycerolates: Synthesis and Characterization – Cited by 2
  • 🌿 Investigation of Chronic Toxicity of a Pharmacological Composition Based on Bacteriocin-nisin and Silicon Glycerolates – Cited by 1
  • πŸ”¬ Magnetic Nanocomposite Materials Based on Fe3O4 Nanoparticles with Iron and Silica Glycerolates Shell: Synthesis and Characterization – Cited by 4
  • βš—οΈ Standardization of the Pharmaceutical Substance of the Silicon-zinc-boron-containing Glycerohydrogel – Cited by 1